1. Home
  2. SAMG vs GLSI Comparison

SAMG vs GLSI Comparison

Compare SAMG & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAMG
  • GLSI
  • Stock Information
  • Founded
  • SAMG 2002
  • GLSI 2006
  • Country
  • SAMG United States
  • GLSI United States
  • Employees
  • SAMG N/A
  • GLSI N/A
  • Industry
  • SAMG Investment Managers
  • GLSI Biotechnology: Pharmaceutical Preparations
  • Sector
  • SAMG Finance
  • GLSI Health Care
  • Exchange
  • SAMG Nasdaq
  • GLSI Nasdaq
  • Market Cap
  • SAMG 170.2M
  • GLSI 159.8M
  • IPO Year
  • SAMG 2013
  • GLSI 2020
  • Fundamental
  • Price
  • SAMG $18.41
  • GLSI $11.95
  • Analyst Decision
  • SAMG
  • GLSI Strong Buy
  • Analyst Count
  • SAMG 0
  • GLSI 1
  • Target Price
  • SAMG N/A
  • GLSI $38.00
  • AVG Volume (30 Days)
  • SAMG 17.4K
  • GLSI 24.6K
  • Earning Date
  • SAMG 03-06-2025
  • GLSI 04-14-2025
  • Dividend Yield
  • SAMG 4.21%
  • GLSI N/A
  • EPS Growth
  • SAMG N/A
  • GLSI N/A
  • EPS
  • SAMG 0.79
  • GLSI N/A
  • Revenue
  • SAMG $120,231,000.00
  • GLSI N/A
  • Revenue This Year
  • SAMG $7.36
  • GLSI N/A
  • Revenue Next Year
  • SAMG $6.62
  • GLSI N/A
  • P/E Ratio
  • SAMG $24.03
  • GLSI N/A
  • Revenue Growth
  • SAMG 2.45
  • GLSI N/A
  • 52 Week Low
  • SAMG $13.93
  • GLSI $10.52
  • 52 Week High
  • SAMG $19.20
  • GLSI $21.44
  • Technical
  • Relative Strength Index (RSI)
  • SAMG 50.45
  • GLSI 40.69
  • Support Level
  • SAMG $17.86
  • GLSI $11.87
  • Resistance Level
  • SAMG $19.04
  • GLSI $12.95
  • Average True Range (ATR)
  • SAMG 0.43
  • GLSI 0.59
  • MACD
  • SAMG 0.02
  • GLSI -0.05
  • Stochastic Oscillator
  • SAMG 46.61
  • GLSI 25.19

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. Its Product Candidates include; GP2, a HER2/neu transmembrane peptide that elicits a targeted immune response against HER2/neu-expressing cancers, GM-CSF Immunoadjuvant has been shown to enhance monocyte and neutrophil cytotoxicity against melanoma tumor cells and to enhance activity-dependent cellular cytotoxicity of monocytes and neutrophils against targets coated with the anti-ganglioside antibodies, and Cancer immunotherapy seeks to stimulate an individual's immune system to selectively attack cancer cells to inhibit the spread of cancer.

Share on Social Networks: